| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Avadel Pharmaceuticals plc (NASDAQ: AVDL)
AVDL Technical Analysis
5
| As on 9th Jun 2023 AVDL STOCK Price closed @ 15.07 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 5.77 & Strong Buy for SHORT-TERM with Stoploss of 6.98 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AVDLSTOCK Price
| Open | 15.14 | Change | Price | % |
| High | 15.57 | 1 Day | -0.02 | -0.13 |
| Low | 14.94 | 1 Week | 1.23 | 8.89 |
| Close | 15.07 | 1 Month | 4.88 | 47.89 |
| Volume | 658691 | 1 Year | 7.55 | 100.40 |
| 52 Week High 15.50 | 52 Week Low 1.07 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| AVDL Daily Charts |
AVDL Intraday Charts |
Whats New @ Bazaartrend |
AVDL Free Analysis |
|
|
AVDL Important Levels Intraday
| RESISTANCE | 16.28 |
| RESISTANCE | 15.89 |
| RESISTANCE | 15.65 |
| RESISTANCE | 15.41 |
| SUPPORT | 14.73 |
| SUPPORT | 14.49 |
| SUPPORT | 14.25 |
| SUPPORT | 13.86 |
AVDL Forecast April 2024
| 4th UP Forecast | 21.12 |
| 3rd UP Forecast | 19.18 |
| 2nd UP Forecast | 17.98 |
| 1st UP Forecast | 16.78 |
| 1st DOWN Forecast | 13.36 |
| 2nd DOWN Forecast | 12.16 |
| 3rd DOWN Forecast | 10.96 |
| 4th DOWN Forecast | 9.02 |
AVDL Weekly Forecast
| 4th UP Forecast | 16.52 |
| 3rd UP Forecast | 16.05 |
| 2nd UP Forecast | 15.77 |
| 1st UP Forecast | 15.48 |
| 1st DOWN Forecast | 14.66 |
| 2nd DOWN Forecast | 14.37 |
| 3rd DOWN Forecast | 14.09 |
| 4th DOWN Forecast | 13.62 |
AVDL Forecast2024
| 4th UP Forecast | 43.53 |
| 3rd UP Forecast | 34.4 |
| 2nd UP Forecast | 28.76 |
| 1st UP Forecast | 23.12 |
| 1st DOWN Forecast | 7.02 |
| 2nd DOWN Forecast | 1.38 |
| 3rd DOWN Forecast | -4.26 |
| 4th DOWN Forecast | -13.39 |
Avadel Pharmaceuticals plc ( NASDAQ USA Symbol : AVDL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AVDL Business Profile
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. The company's lead product candidate is FT218, a formulation of sodium oxybate which is in a Phase 3 clinical trial for the treatment excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland. Address: 10 Earlsfort Terrace, Dublin, Ireland, 2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service